ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 743530 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 743530; 2) Community: the network communities that were significantly associated with the response to NSC 743530; 3) Molecule: the relationships between components within communities and NSC 743530; 4) MDR: the compounds that were significantly associated with the NSC 743530.

NSC Compound Enrichment Correlation
NSC 131257 Null 0.0342636096654271 0.48341974
NSC 143019 METHANEDIAMINE, N,N'-BIS(1,3,4-THIADIAZOL-2-YL)- 0.0342636096654271 -0.055420903
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0342636096654271 0.51554991
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0342636096654271 0.33203629
NSC 323241 3-Azabicyclo[3.2.2]nonane-3-carboselenoic acid, [1-(2-pyridinyl)ethylidene]hydrazide 0.0342636096654271 0.56965851
NSC 333054 Adriamycin, tetrahydropyranyl 0.0342636096654271 0.25309649
NSC 34533 Fulcin 0.0342636096654271 0.35766656
NSC 347217 Carbamic acid, [5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido[3,4-b]pyrazin-7-yl]-, ethyl ester, monohydrochloride 0.0342636096654271 0.39699522
NSC 373355 Saframycin R 0.0342636096654271 0.31731281
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0342636096654271 0.10620288
Total:122  Current:79    [First] [Prev] [Next] [Last]